New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Check below for free stories on ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
July 31, 2014
19:08 EDTREGNSanofi raises stake in Regeneron to 22.5% from 21.6%
Subscribe for More Information
15:38 EDTCTRXNotable companies reporting before tomorrow's open
Subscribe for More Information
09:30 EDTEQIXEquinix downgraded to Equal Weight from Overweight at Stephens
08:01 EDTEQIXEquinix price target raised to $259 from $240 at Canaccord
Subscribe for More Information
07:57 EDTWDCWestern Digital price target raised to $120 from $105 at Stifel
Subscribe for More Information
07:17 EDTEQIXEquinix price target raised to $245 from $215 at RBC Capital
Subscribe for More Information
07:17 EDTDISCADiscovery sees FY14 revenue $6.45B-$6.53B, consensus $6.47B
Subscribe for More Information
07:16 EDTDISCADiscovery reports Q2 adjusted EPS $1.16, consensus 95c
Subscribe for More Information
06:24 EDTWDCWestern Digital price target raised to $116 from $100 at Citigroup
Subscribe for More Information
July 30, 2014
18:54 EDTEQIXOn The Fly: After Hours Movers
UP AFTER EARNINGS: VistaPrint (VPRT), up 20.6% after reporting better than expected quarterly results and guiding fiscal 2015 higher than analyst estimates... Mobileiron (MOBL), up 16.5%... LivePerson (LPSN), up 10.6%... Equinix (EQIX), up 1.1%... Whiting Petroleum (WLL), up 1.2%. DOWN AFTER EARNINGS: Glu Mobile (GLUU), down 9.9% after reporting second quarter results and that it will acquire Cie Games for $100M in cash and stock... ServiceNow (NOW), down 5.8%... Akamai (AKAM), down 5.3%... Westell Technologies (WSTL), down 7.5%... Solazyme (SZYM), down 4%... Whole Foods (WFM), down 3.4% after reporting third quarter results and guidance for the fourth quarter and fiscal 2014... Kraft Foods (KRFT), down 1.6%... Lam Research (LRCX), down 1.6%... Yelp (YELP), reverses in after-hours trading and shares are down marginally after reporting a decline in newly added businesses. ALSO LOWER: Penn Virginia (PVA), down 2.1% after announcing that it has sold Eagle Ford Shale acreage rights for $150M... Yum! Brands (YUM), down 5.6% after saying that OSI had a "significant, negative impact" to its sales in China.
17:13 EDTWDCWestern Digital sees Q1 EPS $1.95-$2.05, consensus $2.06
Sees Q1 revenue $3.8B-$3.9B, consensus $3.84B. Guidance from Q4 earnings call.
16:31 EDTREGNRegeneron, Sanofi announce plan to use priority review voucher for alirocumab
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that the companies intend to use a FDA rare pediatric disease priority review voucher in connection with the Biologics License Application, or BLA, submission for alirocumab. The priority review voucher entitles the holder to designate a BLA for priority review, which provides for an expedited 6-month review from the filing date instead of the standard 10-month review. Regeneron Ireland, an indirect, wholly-owned subsidiary of Regeneron Pharmaceuticals, purchased the voucher from BioMarin GALNS, a direct, wholly-owned subsidiary of BioMarin Pharmaceutical (BMRN), which had received it through the FDA's rare pediatric disease priority review voucher program. Sanofi and Regeneron will equally share the purchase price of $67.5M. Sanofi and Regeneron expect to submit U.S. and EU regulatory submissions for alirocumab before year end.
16:24 EDTREGNBioMarin sells priority review voucher for $67.5M to Regeneron
BioMarin Pharmaceutical (BMRN) announced that it has sold the Rare Pediatric Disease Priority Review Voucher it obtained in February of this year. The company received the voucher under an FDA program intended to encourage the development of treatments for rare pediatric diseases. BioMarin was awarded the voucher when it received approval of VIMIZIM, a new biological product for patients with Mucopolysaccharidosis type IVA, also known as Morquio A syndrome. BioMarin received $67.5M from Regeneron Ireland, an indirect, wholly-owned subsidiary of Regeneron Pharmaceuticals (REGN), in exchange for the voucher. "Leveraging the sale of the Priority Review Voucher to reinvest in products to treat rare and ultra-rare diseases makes the most sense for BioMarin given our stage of growth," said Jean-Jacques Bienaimé, CEO of BioMarin.
16:23 EDTWDCWestern Digital reports Q4 EPS $1.85, consensus $1.74
Subscribe for More Information
16:17 EDTEQIXEquinix raises 2014 revenue outlook to $2.425B-$2.435B, consensus $2.41B
Subscribe for More Information
16:17 EDTEQIXEquinix sees Q3 revenue $614M-$618M, consensus $606.25M
Subscribe for More Information
16:16 EDTEQIXEquinix reports Q2 EPS with charge 22c, won't compare to consensus 81c
Reports Q2 revenue $605.2M, consensus $596M. EPS includes a charge to the income statement of $51.2M for the loss on debt extinguishment related to the exchanges of the convertible subordinated notes.
15:31 EDTEQIX, WDCNotable companies reporting after market close
Subscribe for More Information
15:22 EDTWDCWestern Digital technical comments ahead of results
Subscribe for More Information
13:14 EDTWDCEarnings Preview: Western Digital shares rise ahead of Q4 report
Western Digital (WDC) is set to report fourth quarter earnings on Wednesday, July 30, with a conference call scheduled for 5:00 pm ET. Western Digital provides digital content storage solutions, and is primarily engaged in the sale of hard drives for both personal and business use. EXPECTATIONS: Analysts are looking for earnings per share of $1.74 on revenue of $3.59B, according to First Call. The consensus range for EPS is $1.66-$1.88 on revenue of $3.54B-$3.69B. On its third quarter earnings conference call, the company said it sees Q4 EPS of $1.65-$1.75, which was below then-consensus estimates for $1.89. Western Digital also guided to Q4 revenue of $3.5B-$3.6B, which was roughly in-line with then-estimates for $3.74B. The company’s Q4 outlook marked the third consecutive quarter that its guidance disappointed. LAST QUARTER: On Wednesday April 30, Western Digital reported Q3 EPS of $1.94 on revenue of $3.7B, which compared to estimates for earnings of $1.88 on revenue of $3.74B. STREET RESEARCH: Wall Street research has been fairly quiet on Western Digital during the quarter. On May 14, Barclays upgraded Western Digital to Overweight from Equalweight citing the potential for increased buyback activity and cost synergies. The firm raised its price target for the shares to $98 from $95. On July 1, Brean Capital noted that it sees "material" earnings upside in the June quarter for Western Digital and Seagate (STX). The firm explained that it loves both stocks in regards to the short and long terms and it urged investors to get into the names at current levels. Brean had a $125 price target for Western Digital. Deutsche Bank increased its price target on Western Digital to $118 from $100 on July 14, citing expectations that PC market strength will continue and that enterprise will recover in 2H14. Deutsche said it expected Western Digital to report June quarter results above guidance due to market share gains and it maintained the stock with a Buy rating. On July 16, RW Baird upgraded Western Digital to Outperform from Neutral citing PC strength and renewed traction in Hyperscale Cloud and Enterprise. The firm upped its price target on the shares to $120 from $95. PRICE ACTION: Shares of Western Digital have increased 15.63% since last quarter's earnings report. In afternoon trading ahead of its Q4 report, Western Digital is up almost 1% to $101.50.
12:33 EDTREGNRegeneron, Sanofi likely to file alirocumab BLA this year, says Piper Jaffray
Subscribe for More Information
12:27 EDTREGNOn The Fly: Midday Wrap
Subscribe for More Information
08:56 EDTEQIXEquinix August weekly volatility elevated into Q2 and sales outlook
Subscribe for More Information
08:08 EDTREGNSanofi and Regeneron report positive Phase 2 results of alirocumab
Subscribe for More Information
July 29, 2014
18:38 EDTREGNRegeneron receives FDA approval for EYLEA for treatment of DME
Regeneron Pharmaceuticals announced that the FDA has approved EYLEA Injection for the treatment of Diabetic Macular Edema, or DME. The approval of EYLEA in DME was based on the one-year data from the phase 3 VISTA-DME and VIVID-DME studies of 862 patients. In Europe, the Committee for Medicinal Products for Human Use has given a positive opinion recommending approval for EYLEA in the treatment of DME. Regulatory submissions have also been made in Japan, Asia Pacific, and Latin America for the treatment of DME. In Japan, EYLEA has been additionally submitted for approval to regulators for the treatment of choroidal neovascularization secondary to pathologic myopia. A regulatory submission has been made in the U.S. and Europe for EYLEA for the treatment of Macular Edema following Branch Retinal Vein Occlusion.
16:32 EDTVRSKVerisk Analytics reports Q2 adjusted EPS 57c, consensus 56c
Subscribe for More Information
15:53 EDTVRSKNotable companies reporting after market close
Subscribe for More Information
07:55 EDTCTRXLeerink a buyer of Catamaran ahead of Q2 results
Leerink says it's a buyer of Catamaran (CTRX) ahead of the company's Q2 results as it believes shares have more room to run. The firm is cautious on Express Scripts (ESRX) after hearing from a specialist that service challenges may impact the company's 2015 and 2016 selling seasons. The firm remains positive on CVS Caremark (CVS), but notes shares have outperformed and the company could see retail pressure from recent drug inflation trends.
July 24, 2014
16:34 EDTSBACSBA Communications sees FY14 revenue $1.5B-$1.52B, consensus $1.48B
Subscribe for More Information
16:33 EDTSBACSBA Communications sees Q3 revenue $380.5M-$390.5M, consensus $379M
Subscribe for More Information
16:31 EDTSBACSBA Communications reports Q2 EPS (7c), consensus (1c)
Subscribe for More Information
10:43 EDTLBTYALiberty Global offers to sell Film1 to win Ziggo deal approval, Reuters says
Subscribe for More Information
10:03 EDTEQIXOn The Fly: Analyst Downgrade Summary
Today's noteworthy initiations include: CECO Environmental (CECE) initiated with a Buy at Canaccord... CorMedix (CRMD) initiated with a Buy at Roth Capital... CyrusOne (CONE) initiated with an Equal Weight at Barclays... Dangdang (DANG) initiated with a Buy at Citigroup... Equinix (EQIX) initiated with an Equal Weight at Barclays... FactSet (FDS) initiated with a Buy at Jefferies... JMP Group (JMP) initiated with an Outperform at Barrington... Markit (MRKT) initiated with a Hold at Jefferies... Thomson Reuters (TRI) initiated with a Hold at Jefferies... Wheeler REIT (WHLR) initiated with a Buy at Maxim... Zafgen (ZFGN) initiated with an Outperform at Leerink.
05:33 EDTEQIXEquinix initiated with an Equal Weight at Barclays
Subscribe for More Information
July 23, 2014
15:31 EDTLBTYA, LMCAMalone sees Time Warner bid unlikely from tech companies, WSJ reports
Subscribe for More Information
15:00 EDTLMCALiberty Media's Malone sees tech players unlikely to bid Time Warner, DJ says
Subscribe for More Information
July 22, 2014
11:10 EDTEQIXNetflix EU expansion modestly positive for Equinix, InterXion, says Wells Fargo
Subscribe for More Information
10:46 EDTSBACHigh option volume stocks: SBAC KS EDU PII GALT EJ AXL TSEM HLF BCOR
Subscribe for More Information
07:08 EDTADIAnalog Devices completes tender offer for Hittite Microwave shares
Analog Devices (ADI) announced it has completed its tender offer to purchase all outstanding shares of common stock of Hittite Microwave Corporation (HITT) for $78.00 per share in cash, and ADI has accepted for payment and will promptly pay the depositary for all validly tendered shares. ADI expects to complete the acquisition of Hittite Microwave later today and will issue a press release to notify stakeholders. The tender offer expired at 12:00 midnight, New York City time, at the end of July 21, 2014. As of the expiration of the tender offer, 23,291,991 shares of Hittite Microwave common stock had been validly tendered and not validly withdrawn, representing approximately 74.2% of Hittite Microwave’s outstanding shares of common stock.
July 21, 2014
10:02 EDTREGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Adeptus Health (ADPT) initiated with a Buy at Dougherty... Amphastar (AMPH) initiated with a Buy at Jefferies... Eclipse Resources (ECR) initiated with a Neutral at SunTrust... Fidelity National (FNF) initiated with a Buy at SunTrust... First American (FAF) initiated with a Buy at SunTrust... GoPro (GPRO) initiated with a Hold at Stifel... Imprivata (IMPR) initiated with an Outperform at Wells Fargo... Lifetime Brands (LCUT) initiated with a Buy at Sidoti... Materialise (MTLS) initiated with a Buy at BB&T... Regeneron (REGN) initiated with a Buy at Argus... STAG Industrial (STAG) initiated with a Buy at Sandler O'Neill... Signature Group (SGGH) initiated with a Buy at B. Riley... TCP International (TCPI) initiated with a Buy at Canaccord... Tessera (TSRA) initiated with a Buy at Craig-Hallum... Xunlei (XNET) initiated with a Perform at Oppenheimer.
07:42 EDTREGNRegeneron initiated with a Buy at Argus
Target $375.
06:34 EDTDISCADeals increase vulnerability of small cable stations, NY Times reports
Recent major M&A deals, if approved, would make the owners of small cable TV channels more vulnerable, industry executives and analysts say, according to The New York Times. It is uncertain if the small cable TV networks will be acquired or disappear, the newspaper stated. Owners of small cable channels include Discovery Communications (DISCA), Scripps Networks (SNI), and Crown Media (CRWN). Reference Link
July 18, 2014
12:21 EDTDISCACable ad upfront volumes may drop 4% or more, WSJ says
Two of the U.S.'s biggest marketers, Procter & Gamble (PG) and General Motors (GM), have pulled back on their TV network advertising commitments in advance of the "upfront" selling season for cable networks, said The Wall Street Journal, citing people familiar with the matter. The overall volume of ad dollars committed to cable networks during the upfront, which is still under way, could be down 4% or more from last year, people familiar with the situation said. Notable owners of cable television stations include 21st Century Fox (FOXA), Time Warner (TWX), Disney (DIS), CBS (CBS), Comcast (CMCSA), Discovery (DISCA), Viacom (VIAB), and AMC Networks (AMCX). The report added that cutbacks partly reflect a shift of tv ad budgets to digital media, including online video. Google (GOOG) has a large presence in online video with YouTube and Facebook (FB) is taking steps to grow in the area. Reference Link
07:25 EDTWDCWestern Digital has positive read through from Seagate results, says RBC Capital
Subscribe for More Information
06:10 EDTREGNRegeneron announces results from Phase 3 VIVID-DME trial of EYLEA
Subscribe for More Information
July 17, 2014
17:56 EDTWDCWestern Digital down 1.2% after peer Seagate reports Q4 results
05:49 EDTLBTYALiberty Global acquires 6.4% stake in ITV from BSkyB
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use